March 2001
Worldwide Biotech;Mar2001, Vol. 13 Issue 3, p2
Trade Publication
Reports that Nortran Pharmaceuticals Inc. has announced that its clinical candidate, RSD1235, showed efficacy in terminating atrial fibrillation.


Related Articles

  • Don't let AF put you in the ER.  // Medical Update;Apr94, Vol. 17 Issue 10, p6 

    Provides information on atrial fibrillation (AF) or irregular heartbeat. Definition of AF; Symptoms; Risks.

  • INVESTIGATION AND NON-DRUG MANAGEMENT OF ATRIAL FIBRILLATION. Lip, Gregory Y.H.; Singh, S.P. // BMJ: British Medical Journal (International Edition);12/9/95, Vol. 311 Issue 7019, p1562 

    Focuses on the non-drug management for atrial fibrillation. Investigation of a patient with atrial fibrillation; Using a 24 hour Holter monitor to document paroxysmal atrial fibrillation; Indication for exercise testing; Ablation and implantation of pacemaker; Management of the sick sinus syndrome.

  • Identification of patients with atrial fibrillation in general practice: A study of screening... Sudlow, Mark; Rodgers, Helen; Kenny, Rose Anne; Thomson, Richard // BMJ: British Medical Journal (International Edition);08/01/98, Vol. 317 Issue 7154, p327 

    Presents a study which focused on atrial fibrillation. What is atrial fibrillation; Identification of two methods for detecting atrial fibrillation in people; Method used for the study; Results of the study.

  • Atrial fibrillation and cognitive function: A case control study.  // Age & Ageing;Nov97, Vol. 26 Issue 6, p6 

    Presents an abstract of the article `Atrial Fibrillation and Cognitive Function: A Case Control Study,' by J.E. O'Connell, J.M. French, et al.

  • Atrial Fibrillation in the Elderly. Nantsupawat, Teerapat; Nugent, Kenneth; Phrommintikul, Arintaya // Drugs & Aging;2013, Vol. 30 Issue 8, p593 

    Atrial fibrillation (AF) is the most common arrhythmia in older adults with a prevalence of 9 % in adults aged 80 years or older. AF patients have a five times greater risk of developing stroke than the general population. Using anticoagulants for stroke prevention in the elderly becomes a...

  • AETIOLOGY, PATHOPHYSIOLOGY, AND CLINICAL FEATURES. Lip, Gregory Y.H.; Beevers, D. Gareth // BMJ: British Medical Journal (International Edition);11/25/95, Vol. 311 Issue 7017, p1425 

    Provides information on atrial fibrillation. Causes; Pathophysiology and electrophysiology; Symptoms; Complications.

  • Lone atrial fibrillation in vigorously exercising middle aged men: Case-control study. Karjalainen, Jouko; Kujala, Urho M.; Kaprio, Jaakko; Sarna, Seppo; Viitasalo, Matti // BMJ: British Medical Journal (International Edition);06/13/98, Vol. 316 Issue 7147, p1784 

    Compares the prevalence of atrial fibrillation in middle aged men involved in intense exercises, highlighting the role of regular exercise in reducing the risk of cardiovascular morbidity. Details on the diagnosis of lone atrial fibrillation in men without known risk factors; How exercise can...

  • HISTORY, EPIDEMIOLOGY, AND IMPORTANCE OF ATRIAL FIBRILLATION. Lip, Gregory Y.H.; Beevers, D. Gareth // BMJ: British Medical Journal (International Edition);11/18/95, Vol. 311 Issue 7016, p1361 

    Discusses the history, epidemiology and importance of atrial fibrillation. Diagnosis of atrial fibrillation; Incidence; Therapeutic benefits in treating atrial fibrillation; Complications of atrial fibrillation. INSET: The grateful patients of Arles, by A.L. Wyman..

  • Atrial fibrillation and impaired left ventricular function are risk factors for atrial septal defect closure in patients over 30 years of age.  // Cardiology in the Young;May2006 Supplement, Vol. 16 Issue S2, p77 

    The article presents the abstract "Atrial fibrillation and impaired left ventricular function are risk factors for atrial septal defect closure in patients over 30 years of age."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics